在骨关节炎中除氧化酶:从机制到治疗方法
Zhikun Yuan1, Guanhao Chen2, Yanhui Li3
1Department of Orthopedics, Shijie Hospital of Dongguan City, Dongguan, China.
Orthopedic reviews
|October 3, 2025
概括
脱化酶 (DUBs) 通过调节蛋白质稳定性,在骨关节炎 (OA) 中发挥关键作用. 针对特定的DUB显示出开发新的OA治疗方法的希望,但需要进一步的研究.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 类风湿病学 类风湿病学
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,涉及软骨侵蚀,炎症和疼痛.
- 脱化酶 (DUBs) 通过控制蛋白质降解,在OA病变发生过程中至关重要.
- 特定的DUBs影响关键路径,如炎症,氧化应激和细胞死亡在OA.
研究的目的:
- 阐明DUBs调节OA病变的机制.
- 审查DUB作为OA治疗点的潜力.
- 讨论开发选择性DUB抑制剂用于OA治疗的挑战.
主要方法:
- 对OA中DUB函数的积累证据的审查.
- 分析DUBs在稳定或降解涉及OA的关键蛋白质中的作用.
- 在小鼠OA模型中检查DUB抑制剂研究的临床前数据.
主要成果:
- 像USP7,USP15,USP13,USP3,USP49,USP5和USP14这样的DUB不同调节OA路径.
- 抑制或沉默特定的DUBs (例如,USP7,USP14,USP15,USP49) 减少了小鼠模型中的软骨损失和疼痛.
- DUBs被确定为用于调节OA中的蛋白质循环的可用药物标.
结论:
- DUBs是OA病变的关键调节者,并代表了有前途的治疗点.
- 选择性DUB抑制剂通过调节依赖于无素的蛋白质循环,具有治疗OA的潜力.
- 对DUB抑制剂的临床疗效和安全性的进一步验证对于未来的OA疗法至关重要.
相关概念视频
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.1K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.1K
3.1K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Covalently Linked Protein Regulators
8.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.7K


